Related references
Note: Only part of the references are listed.Molecular characterization of selectively vulnerable neurons in Alzheimer's disease
Kun Leng et al.
NATURE NEUROSCIENCE (2021)
AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery
Yadi Zhou et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Gene co-expression in the interactome: moving from correlation toward causation via an integrated approach to disease module discovery
Paola Paci et al.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2021)
Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease
Jielin Xu et al.
GENOME RESEARCH (2021)
Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes
Jeremy Schwartzentruber et al.
NATURE GENETICS (2021)
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease
Douglas P. Wightman et al.
NATURE GENETICS (2021)
Advancing the use of genome-wide association studies for drug repurposing
William R. Reay et al.
NATURE REVIEWS GENETICS (2021)
Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab
Gil D. Rabinovici
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease
Jiansong Fang et al.
NATURE AGING (2021)
Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease
Yingyue Zhou et al.
NATURE MEDICINE (2020)
Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing
Jiansong Fang et al.
MEDICINAL RESEARCH REVIEWS (2020)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Reverting Metabolic Dysfunction in Cortex and Cerebellum of APP/PS1 Mice, a Model for Alzheimer's Disease by Pioglitazone, a Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Agonist
Kai Lun Chang et al.
MOLECULAR NEUROBIOLOGY (2019)
Single-cell transcriptomic analysis of Alzheimer's disease
Hansruedi Mathys et al.
NATURE (2019)
A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data
Quan Wang et al.
NATURE NEUROSCIENCE (2019)
Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age
Aliza P. Wingo et al.
NATURE COMMUNICATIONS (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
A single-cell atlas of entorhinal cortex from individuals with Alzheimer's disease reveals cell-type-specific gene expression regulation
Alexandra Grubman et al.
NATURE NEUROSCIENCE (2019)
A genome-wide positioning systems network algorithm for in silico drug repurposing
Feixiong Cheng et al.
NATURE COMMUNICATIONS (2019)
Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners
Rishi J. Desai et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk
Iris E. Jansen et al.
NATURE GENETICS (2019)
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
Vivek Swarup et al.
NATURE MEDICINE (2019)
Comparative profiling of the synaptic proteome from Alzheimer's disease patients with focus on the APOE genotype
Raphael Hesse et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
Ying Hong Li et al.
NUCLEIC ACIDS RESEARCH (2018)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Mitochondrial protective mechanism of simvastatin protects against amyloid β peptide-induced injury in SH-SY5Y cells
Yunzi Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics
Dong Kyu Kim et al.
MOLECULAR NEURODEGENERATION (2018)
PharmGKB: A worldwide resource for pharmacogenomic information
Julia M. Barbarino et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2018)
Network-based approach to prediction and population-based validation of in silico drug repurposing
Feixiong Cheng et al.
NATURE COMMUNICATIONS (2018)
An integrative functional genomics framework for effective identification of novel regulatory variants in genome-phenome studies
Junfei Zhao et al.
GENOME MEDICINE (2018)
Genomics: New Light on Alzheimer's Disease Research
Yeong Ju Jung et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model
Hong Wang et al.
MOLECULAR NEURODEGENERATION (2018)
Be open about drug failures to speed up research
Enrica Alteri et al.
NATURE (2018)
Re-thinking Alzheimer's disease therapeutic targets using gene-based tests
Man Ki Kwok et al.
EBIOMEDICINE (2018)
Alzheimer's Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database
Steven Lehrer et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2018)
Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer's Disease Treatment
Rafaela Peron et al.
PHARMACEUTICALS (2018)
Comparative effectiveness of allopurinol versus febuxostat for preventing incident dementia in older adults: a propensity-matched analysis
Jasvinder A. Singh et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Pioglitazone for the treatment of Alzheimer's disease
Daniela Galimberti et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Clozapine Improves Memory Impairment and Reduces Aβ Level in the Tg-APPswe/PS1dE9 Mouse Model of Alzheimer's Disease
Yura Choi et al.
MOLECULAR NEUROBIOLOGY (2017)
Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology
P. Dourlen et al.
MOLECULAR PSYCHIATRY (2017)
Open Targets: a platform for therapeutic target identification and validation
Gautier Koscielny et al.
NUCLEIC ACIDS RESEARCH (2017)
Tracing investment in drug development for Alzheimer diseasemissing
Alpha Tom Kodamullil et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Putting the Patient Back Together - Social Medicine, Network Medicine, and the Limits of Reductionism
Jeremy A. Greene et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Amyloid Accumulation Drives Proteome-wide Alterations in Mouse Models of Alzheimer's Disease-like Pathology
Jeffrey N. Savas et al.
CELL REPORTS (2017)
A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease
Nicholas T. Seyfried et al.
CELL SYSTEMS (2017)
Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease
Syeda Mehpara Farhat et al.
CURRENT DRUG TARGETS (2017)
Transgenic autoinhibition of p21-activated kinase exacerbates synaptic impairments and fronto-dependent behavioral deficits in an animal model of Alzheimer's disease
Cyril Bories et al.
AGING-US (2017)
An Expanded View of Complex Traits: From Polygenic to Omnigenic
Evan A. Boyle et al.
CELL (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers
Yuetiva Deming et al.
ACTA NEUROPATHOLOGICA (2017)
Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease
David C. Hondius et al.
ALZHEIMERS & DEMENTIA (2016)
Simvastatin and Atorvastatin Facilitates Amyloid β-Protein Degradation in Extracellular Spaces by Increasing Neprilysin Secretion from Astrocytes through Activation of MAPK/Erk1/2 Pathways
Naoki Yamamoto et al.
GLIA (2016)
Chromosome conformation elucidates regulatory relationships in developing human brain
Hyejung Won et al.
NATURE (2016)
Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease
Tianfang Jiang et al.
PROGRESS IN NEUROBIOLOGY (2016)
Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease
Minghui Wang et al.
GENOME MEDICINE (2016)
Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease
Wanda M. Snow et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Estrogen receptor-α is localized to neurofibrillary tangles in Alzheimer's disease
Chunyu Wang et al.
SCIENTIFIC REPORTS (2016)
Alzheimer's Disease Risk Genes and Mechanisms of Disease Pathogenesis
Celeste M. Karch et al.
BIOLOGICAL PSYCHIATRY (2015)
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer's Disease Model
Yaming Wang et al.
CELL (2015)
Non-coding genetic variants in human disease
Feng Zhang et al.
HUMAN MOLECULAR GENETICS (2015)
The support of human genetic evidence for approved drug indications
Matthew R. Nelson et al.
NATURE GENETICS (2015)
Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C
Borbala Mifsud et al.
NATURE GENETICS (2015)
Uncovering disease-disease relationships through the incomplete interactome
Joerg Menche et al.
SCIENCE (2015)
Alzheimer's disease
Colin L. Masters et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Late-onset Alzheimer disease risk variants mark brain regulatory loci
Mariet Allen et al.
NEUROLOGY-GENETICS (2015)
Selective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB
Vinicia A. Polito et al.
EMBO MOLECULAR MEDICINE (2014)
Genetics of rheumatoid arthritis contributes to biology and drug discovery
Yukinori Okada et al.
NATURE (2014)
An atlas of active enhancers across human cell types and tissues
Robin Andersson et al.
NATURE (2014)
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
David Cook et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Isolation of glia from Alzheimer's mice reveals inflammation and dysfunction
Marie Orre et al.
NEUROBIOLOGY OF AGING (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing
Yvonne Bouter et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer's Disease
Bin Zhang et al.
CELL (2013)
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2013)
Genes and pathways underlying regional and cell type changes in Alzheimer's disease
Jeremy A. Miller et al.
GENOME MEDICINE (2013)
A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
David S. Geldmacher et al.
ARCHIVES OF NEUROLOGY (2011)
A single nucleotide polymorphism in LRP2 is associated with susceptibility to Alzheimer's disease in the Chinese population
Li-Ling Wang et al.
CLINICA CHIMICA ACTA (2011)
Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype
C. Conejero-Goldberg et al.
MOLECULAR PSYCHIATRY (2011)
Carvedilol as a potential novel agent for the treatment of Alzheimer's disease
Jun Wang et al.
NEUROBIOLOGY OF AGING (2011)
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Tomohiko Sato et al.
NEUROBIOLOGY OF AGING (2011)
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks
Gabriela Bindea et al.
BIOINFORMATICS (2009)
Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT2A serotonergic and α1 adrenergic antagonism
Scott D. Philibin et al.
PSYCHOPHARMACOLOGY (2009)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases
Michael P. Mazanetz et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease
LX Zhao et al.
NATURE NEUROSCIENCE (2006)
Identification of HMG-CoA reductase inhibitors as activators for human, mouse and rat constitutive androstane receptor
K Kobayashi et al.
DRUG METABOLISM AND DISPOSITION (2005)
β-amyloid activates the mitogen-activated protein kinase cascade via hippocampal α7 nicotinic acetylcholine receptors:: In vitro and in vivo mechanisms related to Alzheimer's disease
KT Dineley et al.
JOURNAL OF NEUROSCIENCE (2001)
Share Paper
